Player FM 앱으로 오프라인으로 전환하세요!
Biotech Insights: MIT’s Robert Langer on Startups & mRNA Innovation
Manage episode 434387256 series 2635068
In this episode of Startuprad.io, host Joe Menninger sits down with Professor Robert S. Langer, a renowned biotechnologist from MIT. Professor Langer, co-founder of Moderna and holder of over 1,400 patents, shares his expertise on biotech startups, innovation, and the future of mRNA technology.
Explore the critical differences between biotech sectors in Europe and the US, the key factors for biotech startup success, and the importance of great science, intellectual property, and business acumen. Professor Langer also discusses the essential role of government and private sector partnerships in fostering biotech innovation.
Discover insights on:
Biotech landscapes in Europe vs. the US
Success factors for biotech startups
Future of mRNA technology
Government and private sector partnerships
Diversity in research and its benefits
Funding challenges for biotech startups
Advancements in drug delivery systems
Memorable Quotes:
"Great science and intellectual property are the cornerstones of biotech success."
"Diversity in research teams leads to innovative outcomes."
Enjoyed this episode? Leave a review and share it with your network! Subscribe to our podcast for more expert interviews and insights. Join our vibrant community of tech entrepreneurs and stay updated with the latest in biotech innovation.
Links:
Original Blog Post: https://www.startuprad.io/blog
Work with us: https://www.startuprad.io/become-a-partner
Subscribe: https://linktr.ee/startupradio
#Biotech #Startup #Innovation #mRNA #RobertLanger #MIT #ModernMedicine #TechEntrepreneurship #Startupradio #Podcast
94 에피소드
Biotech Insights: MIT’s Robert Langer on Startups & mRNA Innovation
Startup, Venture Capital and Tech News from Germany, Austria and Switzerland
Manage episode 434387256 series 2635068
In this episode of Startuprad.io, host Joe Menninger sits down with Professor Robert S. Langer, a renowned biotechnologist from MIT. Professor Langer, co-founder of Moderna and holder of over 1,400 patents, shares his expertise on biotech startups, innovation, and the future of mRNA technology.
Explore the critical differences between biotech sectors in Europe and the US, the key factors for biotech startup success, and the importance of great science, intellectual property, and business acumen. Professor Langer also discusses the essential role of government and private sector partnerships in fostering biotech innovation.
Discover insights on:
Biotech landscapes in Europe vs. the US
Success factors for biotech startups
Future of mRNA technology
Government and private sector partnerships
Diversity in research and its benefits
Funding challenges for biotech startups
Advancements in drug delivery systems
Memorable Quotes:
"Great science and intellectual property are the cornerstones of biotech success."
"Diversity in research teams leads to innovative outcomes."
Enjoyed this episode? Leave a review and share it with your network! Subscribe to our podcast for more expert interviews and insights. Join our vibrant community of tech entrepreneurs and stay updated with the latest in biotech innovation.
Links:
Original Blog Post: https://www.startuprad.io/blog
Work with us: https://www.startuprad.io/become-a-partner
Subscribe: https://linktr.ee/startupradio
#Biotech #Startup #Innovation #mRNA #RobertLanger #MIT #ModernMedicine #TechEntrepreneurship #Startupradio #Podcast
94 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.